Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for UHT and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for UHT and 80,000+ other tickers.
See exactly how UHT's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for UHT and 80,000+ other tickers.
Universal Health Realty Income Trust (UHT) operates as a real estate investment trust (REIT) dedicated to investing in properties within the healthcare and human services industries. Its portfolio is diverse, encompassing a range of facilities such as acute care hospitals, rehabilitation centers, sub-acute care facilities, medical office buildings, freestanding emergency departments, and childcare centers. The trust currently holds 71 properties across 20 U.S. states, two of which are actively under construction.
Holding high-yield REITs in a taxable account hands the IRS a cut of every dividend for as long as you own the shares, but the Roth version of that same portfolio changes the math in a way most investors never
Universal Health Realty Income Trust is upgraded to 'Buy' with a $39.50/share price target after the stock fell to my suggested entry point. UHT's Q2 2026 FFO rose 5.88% year-on-year, driven by lower interest costs, not revenue growth, and the dividend remains well-covered with an 8.1% yield. Key risks include UHS tenant concentration (40% of revenue), expiring interest rate swaps, and upcoming lease expirations at two medical centers.
A yield above 6% gets attention, but the real question is whether the cash flow behind it survives the next quarter. Four names on this list pass that test, and one very recognizable brand just proved what happens when the answer is no.
A yield above 6% looks like income until the cash flow behind it disappears. Four names on this list pass the coverage test, and one is here specifically because it just failed it.
